The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.
Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.
In Recognition and Prevention of Major Mental and Substance Use Disorders, a team of distinguished participants addresses the problem of prevention of major mental and substance use disorders at many levels—from the DNA molecule to public policy—in order to show how prevention efforts should be informed by a better understanding of etiology and by a knowledge of indicators of vulnerability. The volume addresses issues that are critical precursors to the prevention of mental disorders and offers an understanding of factors that contribute to the disorders' development.
The contributors review genetic methodologies and current findings in mental disorders and show how biological and psychosocial environmental variables may affect vulnerability. Chapters devoted specifically to lessons in prevention drawn from recent research into schizophrenia discuss the implications of prodromal studies and relationships between stress, critical periods, and the development of the disorder. The book includes contributions from NIH representatives on how basic scientific understanding of mental disorders can be translated into public policy. It also features chapters that describe cutting-edge projects in prevention research for Alzheimer's disease, drug dependence, antisocial behavior, and posttraumatic stress disorder. Each chapter reviews clinical implications, contributing to a volume that will benefit clinicians and researchers who share the goal of preventing these debilitating conditions.
Part I: Etiology of Major Mental and Substance Use DisordersChapter 1. Genetic Risk Factors for Mental Disorders: General Principles and State of the ScienceChapter 2. Environmental Determinants of Psychosis: A Focus on Drug AbuseChapter 3. Social Environment and Psychiatric Disorders: A Historical Review Presented on Receipt of the Paul H. Hoch Award
Part II: Vulnerability to Major Mental and Substance Use DisordersChapter 4. Psychobiology of Resilience to Stress: Implications for Prevention of AnxietyChapter 5. Cognitive Vulnerability to Depression: Implications for PreventionChapter 6. Vulnerability to Alcohol and Drug Use Disorders
Part III: Prevention: Lessons From SchizophreniaChapter 7. Treatment of the Schizophrenia ProdromeChapter 8. Adolescent Neurodevelopment: A Critical Period for Preventive InterventionChapter 9. Toward Prevention of Schizophrenia: Early Detection and Intervention
Part IV: NIH Perspectives on PreventionChapter 10. Prospects for the Prevention of Mental Illness: Integrating Neuroscience and BehaviorChapter 11. Drugs and Alcohol: Treating and Preventing Abuse, Addiction, and Their Medical ConsequencesChapter 12. Alcoholism: Developmental Patterns of Drinking and Prevention of Alcohol Use Disorders
Part V: Challenges for the Near FutureChapter 13. Prevention of Alzheimer’s Disease: Principles and ProspectsChapter 14. Five Facts About Preventing Drug DependenceChapter 15. Prevention of Aggressive Behavior Through Middle School Using a First-Grade Classroom-Based InterventionChapter 16. Conceptually Driven Pharmacological Approaches to Acute Trauma